abstract |
The present invention relates to acylhydroxysamic acid substituted by imido and amido to reduce the content of TNFα and inhibit phosphodiesterase in mammals. Specifically, 3- (1,3-dioxoisoindolin-2-yl) -3- (3-ethoxy-4-methoxyphenyl) propanoylamino) propanoate. |